查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576943

排便管理系統 - 市場考察，競爭情形，市場預測(2030年)

Bowel Management Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2023年全球排便管理系統市場規模為14.2億美元，預計2030年將達到17.8億美元，複合年增長率預計為3.98%。由於包括多發性硬化症在內的神經系統疾病的盛行率不斷增加、產品開發活動的增加以及脊髓損傷病例的增加，該市場正在迅速擴大，預計在2024 年至2030 年的預測期內將加速整體成長。

排便管理系統的市場動態

根據世界衛生組織 (WHO) (2024) 的數據，2021 年全球有 1540 萬人患有脊髓損傷。大多數脊髓損傷是由跌倒或暴力行為等創傷造成的，並且是可以預防的。

根據世界衛生組織 (2023) 數據，據報導全球有超過 180 萬人受到多發性硬化症 (MS) 的影響。多發性硬化症影響多種功能，包括認知、情緒、運動、感覺和視覺功能。當免疫系統錯誤地攻擊大腦和脊髓時就會發生這種情況。

脊髓損傷和多發性硬化症都會促使嚴重的腸道功能障礙，因此腸道管理系統在脊髓損傷和多發性硬化症患者的照護中發揮重要作用。對於脊髓損傷患者，腸道管理系統可以幫助鼓勵規律排便，預防大便失禁等併發症，並改善整體生活品質。同樣，多發性硬化症患者常因神經病變而難以控制腸道。實施有效的腸道管理系統可以更好地調節腸道功能，最大限度地減少不適，並促進受這些疾病影響的人的獨立性。

市場主要參與者增加產品開發活動（例如產品發布）也有助於擴大市場收入佔有率。例如，2024 年 2 月，康樂保推出了 Peristeen® Light，這是一種新型經肛門沖洗裝置，旨在幫助患有腸道功能障礙和滲漏的患者。

因此，上述因素共同推動了整個腸道管理系統市場的成長。

然而，感染、皮膚刺激、腸道穿孔等副作用以及替代選擇的可用性可能會對腸道管理系統市場的成長帶來課題。

排便管理系統市場區隔分析

在腸道管理系統市場的產品類型領域，神經調節設備子類別預計將在 2023 年佔據重要的收入佔有率。這是由於神經調節裝置的廣泛使用及其提高其實用性和有效性的能力。

腸道管理系統的神經調節裝置利用電刺激來調節腸道功能，為腸道功能障礙患者提供非侵入性解決方案。這些設備通常具有可調節的刺激設置，可以根據患者的獨特需求進行個人化治療。它們通常包括遠端控製或基於應用程式的介面，以便於使用和監控。

在臨床應用中，神經調節裝置可有效管理大便失禁和便秘等病症，特別是對於患有影響腸道控制的神經系統疾病或創傷的患者。透過刺激骶神經，這些裝置增加腸道蠕動，減少手動幹預的需要，並改善整體腸道功能，從而顯著改善患者的生活品質。

因此，神經調節設備的廣泛使用和各種功能肯定會提高性能和易用性，從而對 2024-2030 年預測期內整個腸道管理系統市場的增長產生重大影響。

北美預計將主導整個腸道管理系統市場。

在所有地區中，北美預計將在 2023 年主導腸道管理系統市場，並在預測期內保持這一水平。帕金森氏症負擔的增加、監管批准的增加以及成熟的醫療基礎設施的存在是推動 2024-2030 年預測期內北美腸道管理系統市場成長的關鍵因素。

本報告提供全球排便管理系統市場相關調查分析，提供各地區市場規模與預測，過去3年的產品/技術開發，市場主要企業，未來的機會等資訊。

目錄

第1章 排便管理系統市場報告的簡介

第2章 排便管理系統市場摘要整理

  • 市場概要

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 排便管理系統市場主要原因的分析

  • 排便管理系統市場促進因素
  • 排便管理系統市場阻礙因素與課題
  • 排便管理系統市場機會

第6章 排便管理系統市場波特的五力分析

第7章 排便管理系統市場評估

  • 各產品類型
    • 設備
    • 配件
  • 各患者類型
    • 成人
    • 兒童
  • 各終端用戶
    • 醫院
    • 門診病人手術中心
    • 居家照護
  • 地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 排便管理系統市場企業與產品的簡介

  • Coloplast Pty Ltd
  • Medtronic
  • ConvaTec Inc.
  • Hollister Incorporated
  • B. Braun Melsungen AG
  • 3M
  • Cardinal Health.
  • BD
  • Dentsply Sirona
  • Norgine
  • Attends Healthcare Products, Inc.
  • Teleflex Incorporated
  • Laborie
  • Consure Medical.
  • Axonics, Inc.
  • Renew Medical Inc

第9章 KOL的見解

第10章 計劃的方法

第11章 關於DelveInsight

第12章 免責聲明，諮詢方式

Product Code: DIMDCL0318

Bowel Management Systems Market by Product Type (Devices [Irrigation Systems, Nerve Modulation Devices, and Others], and Accessories), Patient Type (Adult and Pediatrics), End-User (Hospitals, Ambulatory Surgical Centres, and Homecare), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing prevalence of neurological disorders and growing product developmental activities worldwide

The bowel management systems market was valued at USD 1.42 billion in 2023, growing at a CAGR of 3.98% during the forecast period from 2024 to 2030, in order to reach USD 1.78 billion by 2030. The bowel management systems market is expanding rapidly due to the increasing prevalence of neurological disorders including multiple sclerosis, growing product developmental activities, increasing instances of spinal cord injuries, and others that are expected to escalate the overall growth of the bowel management systems market during the forecast period from 2024 to 2030.

Bowel Management Systems Market Dynamics:

According to the World Health Organization (WHO) (2024) in 2021, 15.4 million people were living with spinal cord injuries globally. Most cases of spinal cord injury result from trauma, including falls, or acts of violence, and are therefore preventable.

As per data from the WHO (2023), it was reported that over 1.8 million people worldwide are affected by Multiple sclerosis (MS). It impacts various functions including cognitive, emotional, motor, sensory, and visual abilities. It occurs when the immune system mistakenly attacks the brain and spinal cord.

Bowel management systems play a crucial role in the care of individuals with spinal cord injuries and multiple sclerosis, as both conditions can lead to significant bowel dysfunction. For those with spinal cord injuries, bowel management systems help facilitate regular bowel movements and prevent complications such as fecal incontinence, enhancing overall quality of life. Similarly, patients with multiple sclerosis often experience challenges in bowel control due to neurological impairments. Implementing effective bowel management systems allows for better regulation of bowel function, minimizing discomfort and promoting independence for individuals affected by these conditions.

Rising product developmental activities such as product launches by the market key player are also contributing in increasing revenue shares for the same. For example, in February 2024, Coloplast launched Peristeen(R) Light, a new transanal irrigation device designed to assist individuals with bowel disorders, specifically those dealing with defecation issues or stool leakage.

Therefore, the factors stated above collectively will drive the overall bowel management systems market growth.

However, side-effects such as infections, skin irritation, and bowel perforation, among others, availability of alternative options, and others may prove to be challenging factors for bowel management systems market growth.

Bowel Management Systems Market Segment Analysis:

Bowel Management Systems Market by Product Type (Devices [Irrigation Systems, Nerve Modulation Devices, and Others], and Accessories), Patient Type (Adult and Pediatrics), End-User (Hospitals, Ambulatory Surgical Centres, and Homecare), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the bowel management systems market, the nerve modulation devices sub-category is expected to have a significant revenue share in the year 2023. This is because of the widespread uses and features of nerve modulation devices that enhance their utility and effectiveness.

Nerve modulation devices for bowel management systems utilize electrical stimulation to regulate bowel function, offering a non-invasive solution for individuals experiencing bowel dysfunction. These devices typically feature adjustable stimulation settings, allowing for personalized treatment tailored to the patient's specific needs. They often include remote control or app-based interfaces for ease of use and monitoring.

In clinical applications, nerve modulation devices are effective in managing conditions such as fecal incontinence and constipation, particularly in patients with neurological disorders or injuries affecting bowel control. By stimulating the sacral nerves, these devices can enhance bowel motility, reduce the need for manual interventions, and improve overall bowel function, thereby significantly enhancing patients' quality of life.

Therefore the widespread uses and various features of nerve modulation devices enhance performance and usability, solidifying the significant impact on the growth of the overall bowel management systems market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall bowel management systems market:

Among all the regions, North America is expected to dominate the bowel management systems market in the year 2023 and is expected to do the same during the forecast period. This is driven by the growing burden of Parkinson's disease, increasing regulatory approval, the presence of well-established healthcare infrastructure, and others, acting as key factors contributing to the growth of the bowel management systems market in the North America region during the forecast period from 2024 to 2030.

Parkinson's Foundation in 2024 stated that, currently near about one million people in the U.S. are living with Parkinson's disease. This number is projected to increase to 1.2 million by 2030. Parkinson's disease is the second-most common neurodegenerative disorder, following Alzheimer's disease. Each year, approximately 90,000 new cases of Parkinson's are diagnosed in the US.

Bowel management systems are essential for individuals with Parkinson's disease, as the condition frequently causes gastrointestinal issues like constipation and fecal incontinence. These systems assist in effective bowel irrigation and evacuation, helping patients maintain dignity and quality of life. As the disease progresses, tailored bowel management becomes critical, enabling patients and caregivers to address bowel dysfunction challenges. Integrating these systems into care plans supports better gastrointestinal health and overall well-being for those affected by Parkinson's disease.

Rising product developmental activities by regulatory bodies in the region will further boost the market for bowel management systems. For example, in February 2022, Medtronic received the USFDA approval for the InterStim X(TM) system, the next generation of the most personalized sacral nerve stimulation therapy for bladder and bowel control.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American bowel management systems market.

Bowel Management Systems Market key players:

Some of the key market players operating in the bowel management systems market include Coloplast Pty Ltd, Medtronic, ConvaTec Inc., Hollister Incorporated, B. Braun Melsungen AG, 3M, Cardinal Health., BD, Dentsply Sirona, Norgine, Attends Healthcare, Products, Inc., Teleflex Incorporated, Laborie, Consure Medical., Axonics, Inc., Renew Medical Inc, and others.

Recent Developmental Activities in the Bowel Management Systems Market:

  • In November 2021, Medtronic announced that the U.S. Food and Drug Administration, granted 510(k) clearance for its PillCam(TM) Small Bowel 3 system, intended for remote endoscopy procedures.
  • In October 2021, Laborie, acquired Pelvalon, Inc., a privately-held medical device company that developed an innovative product Eclipse(TM) System, a non-surgical, patient-controlled device for women suffering from faecal incontinence.
  • In May 2021, Axonics, Inc., a global medical technology company focused on developing and commercializing novel products for the treatment of bladder and bowel dysfunction, received European CE Mark approval for its second-generation Axonics r-SNM(R) implantable neurostimulator (INS) and wireless patient remote control with SmartMRI(TM) technology.

Key Takeaways from the Bowel Management Systems Market Report Study

  • Market size analysis for current bowel management systems market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the bowel management systems market.
  • Various opportunities available for the other competitors in the bowel management systems market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current bowel management systems market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for bowel management systems market growth in the coming future?

Target Audience who can be benefited from this Bowel Management Systems Market Report Study

  • Bowel management systems product providers
  • Research organizations and consulting companies
  • Bowel management systems-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in bowel management systems
  • Various end-users who want to know more about the bowel management systems market and the latest technological developments in the bowel management systems market

Frequently Asked Questions for the Bowel Management Systems Market:

1. What are Bowel Management Systems?

  • The bowel incontinence, also known as faecal incontinence is generally the situation when the patient is not able to control bowel movements which results in involuntary loss of solid or liquid stool. The clinical devices used to manage bowel activity are called bowel management systems.

2. What is the market for Bowel Management Systems?

  • The bowel management systems market was valued at USD 1.42 billion in 2023, growing at a CAGR of 3.98% during the forecast period from 2024 to 2030, to reach USD 1.78 billion by 2030.

3. What are the drivers for the Bowel Management Systems market?

  • The bowel management systems market is expanding rapidly due to the increasing prevalence of neurological disorders including multiple sclerosis, growing product developmental activities, increasing instances of spinal cord injuries, and others that are expected to escalate the overall growth of the bowel management systems market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Bowel Management Systems market?

  • Some of the key market players operating in bowel management systems include Coloplast Pty Ltd, Medtronic, ConvaTec Inc., Hollister Incorporated, B. Braun Melsungen AG, 3M, Cardinal Health., BD, Dentsply Sirona, Norgine, Attends Healthcare, Products, Inc., Teleflex Incorporated, Laborie, Consure Medical., Axonics, Inc., Renew Medical Inc, and others.

5. Which region has the highest share in the Bowel Management Systems market?

  • Among all the regions, North America is expected to dominate the bowel management systems market in the year 2023 and is expected to do the same during the forecast period. This is driven by the growing burden of Parkinson's disease, increasing regulatory approval, the presence of well-established healthcare infrastructure, and others, acting as key factors contributing to the growth of the bowel management systems market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Bowel Management Systems Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Bowel Management Systems Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Bowel Management Systems Market Key Factors Analysis

  • 5.1. Bowel Management Systems Market Drivers
    • 5.1.1. Increasing prevalence of neurological disorders
    • 5.1.2. Growing product developmental activities
    • 5.1.3. Increasing instances of spinal cord injury
    • 5.1.4. Rising aging population
  • 5.2. Bowel Management Systems Market Restraints and Challenges
    • 5.2.1. Side-effects such as infections, skin irritation, and bowel perforation, among others
    • 5.2.2. Availability of alternative options
  • 5.3. Bowel Management Systems Market Opportunities
    • 5.3.1. Development of more biocompatible materials

6. Bowel Management Systems Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Bowel Management Systems Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Devices
      • 7.1.1.1. Irrigation Systems
      • 7.1.1.2. Nerve Modulation Devices
      • 7.1.1.3. Others
    • 7.1.2. Accessories
  • 7.2. By Patient Type
    • 7.2.1. Adult
    • 7.2.2. Pediatrics
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centres
    • 7.3.3. Home Care
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.1.2. Canada Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.1.3. Mexico Bowel Management Systems Market Size in USD million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.2.2. Germany Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.2.4. Italy Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.2.5. Spain Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.2.6. Rest of Europe Bowel Management Systems Market Size in USD million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.3.2. Japan Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.3.3. India Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.3.4. Australia Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.3.5. South Korea Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Bowel Management Systems Market Size in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.4.2. Africa Bowel Management Systems Market Size in USD million (2021-2030)
      • 7.4.4.3. South America Bowel Management Systems Market Size in USD million (2021-2030)

8. Bowel Management Systems Market Company and Product Profiles

  • 8.1. Coloplast Pty Ltd
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Medtronic
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. ConvaTec Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Hollister Incorporated
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. B. Braun Melsungen AG
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. 3M
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Cardinal Health.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. BD
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Dentsply Sirona
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Norgine
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Attends Healthcare Products, Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Teleflex Incorporated
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Laborie
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Consure Medical.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Axonics, Inc.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Renew Medical Inc
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Bowel Management Systems Market in Global (2021-2030)
  • Table 3: Bowel Management Systems Market in Global by Product Type (2021-2030)
  • Table 4: Bowel Management Systems Market in Global by Patient Type (2021-2030)
  • Table 5: Bowel Management Systems Market in Global by End-User (2021-2030)
  • Table 6: Bowel Management Systems Market in Global by Geography (2021-2030)
  • Table 7: Bowel Management Systems Market in North America (2021-2030)
  • Table 8: Bowel Management Systems Market in the United States (2021-2030)
  • Table 9: Bowel Management Systems Market in Canada (2021-2030)
  • Table 10: Bowel Management Systems Market in Mexico (2021-2030)
  • Table 11: Bowel Management Systems Market in Europe (2021-2030)
  • Table 12: Bowel Management Systems Market in France (2021-2030)
  • Table 13: Bowel Management Systems Market in Germany (2021-2030)
  • Table 14: Bowel Management Systems Market in United Kingdom (2021-2030)
  • Table 15: Bowel Management Systems Market in Italy (2021-2030)
  • Table 16: Bowel Management Systems Market in Spain (2021-2030)
  • Table 17: Bowel Management Systems Market in the Rest of Europe (2021-2030)
  • Table 18: Bowel Management Systems Market in Asia-Pacific (2021-2030)
  • Table 19: Bowel Management Systems Market in China (2021-2030)
  • Table 20: Bowel Management Systems Market in Japan (2021-2030)
  • Table 21: Bowel Management Systems Market in India (2021-2030)
  • Table 22: Bowel Management Systems Market in Australia (2021-2030)
  • Table 23: Bowel Management Systems Market in South Korea (2021-2030)
  • Table 24: Bowel Management Systems Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Bowel Management Systems Market in the Rest of the World (2021-2030)
  • Table 26: Bowel Management Systems Market in the Middle East (2021-2030)
  • Table 27: Bowel Management Systems Market in Africa (2021-2030)
  • Table 28: Bowel Management Systems Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Bowel Management Systems Market in Global (2021-2030)
  • Figure 3: Bowel Management Systems Market in Global by Product Type (2021-2030)
  • Figure 4: Bowel Management Systems Market in Global by Patient Type (2021-2030)
  • Figure 5: Bowel Management Systems Market in Global by End-User (2021-2030)
  • Figure 6: Bowel Management Systems Market in Global by Geography (2021-2030)
  • Figure 7: Bowel Management Systems Market in North America (2021-2030)
  • Figure 8: Bowel Management Systems Market in the United States (2021-2030)
  • Figure 9: Bowel Management Systems Market in Canada (2021-2030)
  • Figure 10: Bowel Management Systems Market in Mexico (2021-2030)
  • Figure 11: Bowel Management Systems Market in Europe (2021-2030)
  • Figure 12: Bowel Management Systems Market in France (2021-2030)
  • Figure 13: Bowel Management Systems Market in Germany (2021-2030)
  • Figure 14: Bowel Management Systems Market in United Kingdom (2021-2030)
  • Figure 15: Bowel Management Systems Market in Italy (2021-2030)
  • Figure 16: Bowel Management Systems Market in Spain (2021-2030)
  • Figure 17: Bowel Management Systems Market in the Rest of Europe (2021-2030)
  • Figure 18: Bowel Management Systems Market in Asia-Pacific (2021-2030)
  • Figure 19: Bowel Management Systems Market in China (2021-2030)
  • Figure 20: Bowel Management Systems Market in Japan (2021-2030)
  • Figure 21: Bowel Management Systems Market in India (2021-2030)
  • Figure 22: Bowel Management Systems Market in Australia (2021-2030)
  • Figure 23: Bowel Management Systems Market in South Korea (2021-2030)
  • Figure 24: Bowel Management Systems Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Bowel Management Systems Market in the Rest of the World (2021-2030)
  • Figure 26: Bowel Management Systems Market in the Middle East (2021-2030)
  • Figure 27: Bowel Management Systems Market in Africa (2021-2030)
  • Figure 28: Bowel Management Systems Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis